BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23192913)

  • 1. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study.
    VandenBussche CJ; Sathiyamoorthy S; Owens CL; Burroughs FH; Rosenthal DL; Guan H
    Cancer Cytopathol; 2013 Jan; 121(1):21-8. PubMed ID: 23192913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template.
    Rosenthal DL; Vandenbussche CJ; Burroughs FH; Sathiyamoorthy S; Guan H; Owens C
    Cancer Cytopathol; 2013 Jan; 121(1):15-20. PubMed ID: 23192944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of the Johns Hopkins Hospital Template on urine cytology.
    Wu HH; Redelman M; Chen S; Grignon DJ; Cramer HM
    Diagn Cytopathol; 2015 Aug; 43(8):593-7. PubMed ID: 25721938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
    Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
    Celik B; Kavas G
    Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
    Cowan ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
    Richardson CJ; Pambuccian SE; Barkan GA
    Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
    Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
    Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells.
    Hang JF; Charu V; Zhang ML; VandenBussche CJ
    Cancer Cytopathol; 2017 Sep; 125(9):710-716. PubMed ID: 28581671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma.
    Pierconti F; Martini M; Straccia P; Fiorentino V; Musarra T; Larocca LM; Lopez-Beltran A
    APMIS; 2018 Sep; 126(9):705-709. PubMed ID: 30160022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
    McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
    Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of atypical urine cytology in a tertiary care center.
    Deshpande V; McKee GT
    Cancer; 2005 Dec; 105(6):468-75. PubMed ID: 16080177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
    Vlajnic T; Gut A; Savic S; Bubendorf L
    J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion
    Miki Y; Neat M; Chandra A
    Cytopathology; 2017 Apr; 28(2):88-95. PubMed ID: 27601215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
    Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
    Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of false-negative for high-grade urothelial carcinoma in urine cytology.
    Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH
    Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
    Suo L; Vega I; Thrall M
    J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments.
    Onur I; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2015 Mar; 123(3):186-92. PubMed ID: 25586692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
    Okuda C; Kyotake A; Nakamura A; Itoh T; Kamoshida S; Ohsaki H
    Cytopathology; 2021 Sep; 32(5):654-659. PubMed ID: 34033150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.